Dr. Anne Endmann

“The latest innovations are of little use without transfer into practice. Only optimal framework conditions enable the bridge to be built from the laboratory to industrial application.”
+49 (0) 30 310078-5459

Focus of work

  • Life sciences
  • Pharmaceutical and biotechnology industry
  • Active ingredient and drug developmentTechnology transfer
  • Analyses on reducing bureaucracy
  • Vaccine research and development

Curriculum vitae

Dr. Anne Endmann is a biotechnologist and senior consultant at iit, focusing on innovation transfer in the life sciences. After completing her doctorate at the Helmholtz Centre for Infection Research in Braunschweig, she worked for several years as a project manager in vaccine development at a biotechnology company. Since 2015, she has been advising ministries on innovation policy issues in the field of pharmaceutical and biotechnological research and development, with a focus on the transfer of research results into application. In studies for the vfa, she conducts practical checks in the pharmaceutical industry, investigating how bureaucratic processes can be streamlined in order to strengthen Germany as an attractive location for research, development, and production.

Publications

^
Endmann, Anne (2018): Impfen – kleiner Pieks, große Wirkung, Festschrift „40 Jahre für Innovation und Technik“. VDI/VDE Innovation + Technik GmbH.